TAK (Takeda Pharmaceutical Company Limited) Stock Market Reviews

crown

search

Read and share opinions on TAK (Takeda Pharmaceutical Company Limited) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the

TAK

Takeda Pharmaceutical Company Limited

clarify Drug Manufacturers - Specialty & Generic

bookmark Healthcare

public Japan

Sell Neutral Buy

Latest News

Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
Nov 7, 2025
Accipiter Biosciences Emerges from Stealth with $12.7 Million in Seed Financing to Deliver de novo Protein Therapies for Complex Diseases
Nov 6, 2025
Keros Therapeutics Reports Third Quarter 2025 Financial Results
Nov 5, 2025
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
Nov 3, 2025
Takeda Pharmaceutical (TSE:4502) Margin Miss Reinforces Bearish Narratives After ¥250.7B One-Off Loss
Nov 1, 2025
Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
Oct 30, 2025
HyHub™ and HyHub™ Duo Devices Now Available in the U.S. to Simplify HYQVIA® Infusion Preparation
Oct 27, 2025
A Look at Innovent Biologics (SEHK:1801) Valuation After Strategic Global Partnership With Takeda
Oct 27, 2025
Takeda signs deal worth up to $11.4bn with Innovent for cancer drug hopefuls
Oct 23, 2025
Stifel Canada on Healwell AI's Darwen Platform
Oct 22, 2025
Health Care Roundup: Market Talk
Oct 22, 2025
Innovent Biologics Announces Global Strategic Partnership with Takeda to Bring Innovent's Next Gen IO Backbone Therapy and ADC Molecules to the Global Market
Oct 22, 2025

Reviews